Tag:
Intercept Pharmaceuticals
Latest Headlines
Latest Headlines
Intercept nails $165M diabetes pact with Servier
Intercept Pharmaceuticals has struck a $165 million deal with Les Laboratoires Servier to collaborate on new TGR5 agonists for diabetes and other metabolic ailments. "We are very happy to enter into
Intercept lands $315M Asian pact for liver disease drug
Japan's Dainippon Sumitomo is slapping down $15 million and promising up to $300 million more in milestones in exchange for the rights to Intercept Pharmaceuticals' late-stage liver disease drug in
Intercept Pharma hauls in $25M Series B
Intercept Pharmaceuticals' majority shareholder, the Italian biotech Genextra, is pumping a $25 million Series B into its coffers. "This financing is recognition of the success we have had advancing
